Stay updated on Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial

Sign up to get notified when there's something new on the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A new revision entry v3.5.3 has been added to the record history and the previous v3.5.2 entry has been removed, reflecting an updated revision of the study record.
    Difference
    0.1%
    Check dated 2026-04-29T09:17:17.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page’s footer revision identifier changes from v3.5.0 to v3.5.2 without affecting any study record fields shown on the record history page.
    Difference
    0.1%
    Check dated 2026-04-22T05:34:30.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the Record History page.
    Difference
    0.1%
    Check dated 2026-03-24T10:58:20.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Revision entry v3.4.3 was added to the study record history, and revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-10T02:48:31.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    The record history now includes a new revision v3.4.2 and removes v3.4.1 from the history. This update affects only the history log and not the study data.
    Difference
    0.1%
    Check dated 2026-02-16T15:33:23.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The Record History shows a new revision entry (v3.4.1) added and the previous revision (v3.4.0) removed, reflecting an update to the study record's metadata.
    Difference
    0.1%
    Check dated 2026-02-09T09:50:59.000Z thumbnail image

Stay in the know with updates to Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Magrolimab + Azacitidine after Allo-HCT in High-Risk AML/MDS Clinical Trial page.